SFS
ANIK icon

Sowell Financial Services’s Anika Therapeutics ANIK Stock Holding History

Sowell Financial Services’s Portfolio ANIK Stock Details ANIK Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q2 		– Sell
-1,017
Closed -$41K – 617
2021
Q1 		$41K Buy
1,017
+633
+165% +$24K ﹤0.01% 1735
2020
Q4 		$17K Buy
384
+267
+228% +$10.1K ﹤0.01% 1792
2020
Q3 		$4K Hold
117
– – ﹤0.01% 2030
2020
Q2 		$4K Hold
117
– – ﹤0.01% 1935
2020
Q1 		$3K Hold
117
– – ﹤0.01% 1956
2019
Q4 		$6K Hold
117
– – ﹤0.01% 1823
2019
Q3 		$6K Buy
+117
New +$6.01K ﹤0.01% 1678

Other funds holding ANIK

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Kayne Anderson Rudnick Investment Management
Kayne Anderson Rudnick Investment Management Los Angeles, California $32.2B AUM 10.98% 1-Year Est. Return
Ameriprise
Ameriprise Minneapolis, Minnesota $495B AUM 43.24% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
FWIA
Fort Washington Investment Advisors Cincinnati, Ohio $19.9B AUM 22.19% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Sowell Financial Services's ANIK Position: Q2 2021 in Review

Sowell Financial Services sold out of Anika Therapeutics (ANIK) in Q2 2021, closing a stake of 1,017 shares — an estimated $41K sold.

Sowell Financial Services first reported a position in ANIK in Q3 2019 and held it in 7 quarters. The position peaked at $41K in Q1 2021. 139 funds tracked by Wall St. Rank hold ANIK as of Q2 2021.

  • Sowell Financial Services reported no remaining Anika Therapeutics position as of Q2 2021 after selling out during the quarter.
  • Sowell Financial Services sold 1,017 Anika Therapeutics shares in Q2 2021, an estimated $41K.
  • Sowell Financial Services first reported a position in Anika Therapeutics in Q3 2019 and held it in 7 quarters.
  • Sowell Financial Services's Anika Therapeutics position peaked at $41K in Q1 2021.
  • 139 funds tracked by Wall St. Rank held Anika Therapeutics as of Q2 2021.

Based on Sowell Financial Services's 13F filing for Q2 2021, filed 5 Aug 2021.